Some chimeric switch receptors can promote the tumor-lysing ability of T cells.7–9 Therefore, we assessed the impact of the switch receptor T3/28 on CD19 CAR-T cell cytotoxicity in three human B lymphoma cell lines (Daudi, Raji, and Namalwa) that highly express CD19. This evidence concerns the gene CD19 and neoplasm.